The effect of hydrocortisone and interleukin 4 on allergen-specific IgE production by peripheral blood mononuclear cells from atopic patients.
- Author:
Young Joo CHO
1
;
Soo Jong HONG
;
You Sook CHO
;
Hee Bom MOON
Author Information
1. Dept. of Internal Medicine, Ewha Womans University College of Medicine.
- Publication Type:In Vitro ; Original Article
- Keywords:
Allergen-specific IgE;
Atopy;
Dermatophagoides farinae;
Interleukin 4;
Hydrocortisone
- MeSH:
Asthma;
B-Lymphocytes;
Dermatophagoides farinae;
Enzyme-Linked Immunosorbent Assay;
Humans;
Hydrocortisone*;
Immunoglobulin E*;
Interleukin-4*;
Interleukins*;
Pyroglyphidae
- From:Journal of Asthma, Allergy and Clinical Immunology
2001;21(1):21-27
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Although the basic cellular and molecular requirements for the induction and synthesis of whole human IgE antibody have extensively been investigated, the mechanisms involved in the regulation of allergen-specific IgE synthesis are not yet fully understood. OBJECTIVES: The aims of this study were to elucidate the differences in the total and specific IgE regulation by hydrocortisone(HC) with interleukin 4 (IL-4) between atopics and non-atopics and to determine the relationship between in vitro IgE synthesis and serum IgE levels. METHODS: Peripheral blood mononuclear cells(PBMCs) from sixteen atopic asthma patients sensitive to Dermatophagoides farinae(D.f) and seven non-atopics were cultured with IL-4 and/or HC. Total and D.f-specific IgE in culture supernatant were measured using ELISA and FAST methods respectively. RESULTS: PBMCs from 8 of 16 atopics produced D.f-specific IgE in vitro either spontaneously or by IL-4 and/or HC. HC had more profound effects than IL-4 in these patients. They also showed higher total IgE synthesis by HC, and higher specific serum IgE levels than the others. IL-4 and/or HC did not induce any D.f-specific IgE synthesis by PBMCs from non-atopics. CONCLUSION: These data suggest that atopic patients have allergen-specific B cells that have already been switched to IgE production, probably due to in vivo priming effect of IL-4.
